Serum carbonic anhydrase IX and its prognostic relevance in Vulvar Cancer

International Journal of Gynecological Cancer

Volumn 21, Issue 1, 2011, Pages 141-148

  Kock, Lilli ^a   Mahner, Sven ^a   Choschzick, Matthias ^a   Eulenburg, Christine ^a   Milde Langosch, Karin ^a   Schwarz, Joerg ^a,b   Jaenicke, Fritz ^a   Müller, Volkmar ^a   Woelber, Linn ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Asklepios Clinic North Heidberg   (Germany)

Author keywords

Carbonic anhydrase; Prognosis; Tumor marker; Vulvar cancer

Indexed keywords

CARBONATE DEHYDRATASE IX;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; PREOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME; VULVA CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PREOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VULVAR NEOPLASMS;

EID: 79951476812     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318204c34f     Document Type: Article

References (20)

1. Fischer D, Katalinic A, Mundhenke C, et al. Epidemiologie maligner Erkrankungen der Vagina und Vulva. Onkologe. 2009;15:8-14.
2. van der Sijde R, de Bruijn HW, Krans M, et al. Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva. Gynecol Oncol. 1989;35:227-232. (Pubitemid 19268563)
3. Fang JS, Gillies RD, Gatenby RA. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol. 2008;18:330-337.
4. Wykoff CC, Beasley NJ, Watson PH, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000;60:7075-7083. (Pubitemid 32059187)
5. Chia SK, Wykoff CC, Watson PH, et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol. 2001;19: 3660-3668. (Pubitemid 32786278)
6. Kirkpatrick JP, Rabbani ZN, Bentley RC, et al. Elevated CAIX expression is associated with an increased risk of distant failure in early-stage cervical cancer. Biomark Insights. 2008;3:45-55. (Pubitemid 351279849)
7. Liao SY, Darcy KM, Randall LM, et al. Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010;116:452-458.
8. Tanaka N, Kato H, Inose T, et al. Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma. Br J Cancer. 2008;99:1468-1475.
9. Wilex. Phase III ARISER Study (Adjuvant RENCAREX®Immunotherapy Phase III trial to Study Efficacy in non-metastatic RCC). Available at: http://wwwwilexde/R&D/RENCAREX-PhaseIIIhtm. 2010. Accessed April 15, 2010.
10. Zavada J, Zavadova Z, Zat'ovicova M, et al. Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients. Br J Cancer. 2003;89:1067-1071. (Pubitemid 37239213)
11. Li G, Feng G, Gentil-Perret A, et al. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol. 2008;180:510Y513; discussion 3-4.
12. Choschzick M, Woelber L, Hess S, et al. Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases. Virchows Arch. 2010;56:483-490.
13. Woelber L, Mueller V, Eulenburg C, et al. Serum carbonic anhydrase IX during first-line therapy of ovarian cancer. Gynecol Oncol. 2010;117:183-188.
14. Carney WP. Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers. Expert Rev Mol Diagn. 2007;7:309-319. (Pubitemid 46798620)
15. Fons G, Hasibuan SM, van der Velden J, et al. Validation of tissue microarray technology in endometrioid cancer of the endometrium. J Clin Pathol. 2007;60:500-503. (Pubitemid 46867158)
16. Zhou GX, Ireland J, Rayman P, et al. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials. Urology. 2010;75:257-261.
17. Hyrsl L, Zavada J, Zavadova Z, et al. Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract. Neoplasma. 2009;56:298-302.
18. Loncaster JA, Harris AL, Davidson SE, et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 2001;61:6394-6399. (Pubitemid 32783244)
19. Schmitt A, Barth TF, Beyer E, et al. The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses. Int J Oncol. 2009;34:629-639.
20. Korkeila E, Talvinen K, Jaakkola PM, et al. Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer. 2009;100:874-880.